Design, Synthesis, In Vitro, and In Silico Assessment of Fluoroquinolone‐Sulfonamide Hybrids as Promising Antibacterial Agents
Chemistry & Biodiversity · 2026-05 · 23 (5)
DOI: 10.1002/cbdv.71318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 11.05.2026. Verfasst von Garba Suleiman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Euromed Research Center, Euromed University of Fes (UEMF), Fes 30000, Morocco. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Sulfonamides, Fluoroquinolones, Drug Design. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Euromed University of Fes (UEMF), Morocco, The African Scientific, Research and Innovation Council (ASRIC), National Center for Nuclear Energy, Science and Technology (CNESTEN).
Abstract (Originalsprache)
A new series of hybrid compounds ( 1–6 ) incorporating fluoroquinolone and sulfonamide scaffolds has been synthesized, characterized, and evaluated for antibacterial activity. The analogs were characterized by FT‐IR, 1 H and 13 C NMR, mass spectrometry, and HPLC. Ciprofloxacin ( CPX )‐based derivatives 5 and 6 , bearing 4‐nitrobenzenesulfonyl and 3‐cyanobenzenesulfonyl moieties, demonstrated broad‐spectrum activity against E. coli , S. aureus , and S. typhimurium . Compound 5 showed enhanced activity against S. typhimurium (MIC = 0.5 µg/mL), representing 30‐fold improvement over CPX , and notable efficacy against E. coli (MIC = 2.0 µg/mL). Compound 6 demonstrated consistent potency (MIC = 1.0 µg/mL) across all tested strains, achieving 30‐fold improvement against S. aureus and 15‐fold enhancement against S. typhimurium . Structure–activity relationship (SAR) studies revealed that electron‐withdrawing groups (EWGs) significantly enhanced potency, while electron‐donating groups (EDGs) reduced activity. Molecular docking showed enhanced binding affinities toward relevant bacterial targets: E. coli (PDB ID: 1T7D), S. aureus (PDB ID: 5TW8), and S. typhimurium (PDB ID: 2XF4). ADMET predictions suggested acceptable pharmacokinetic and toxicity profiles. These findings establish EWG‐substituted arylsulfonyl fluoroquinolones, especially compounds 5 and 6 , as promising antibacterial candidates for further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Euromed Research Center, Euromed University of Fes (UEMF), Fes 30000, Morocco.
- The National Center for Nuclear Energy, Science and Technology, CNESTEN, Rabat, Morocco.
Förderung
- Euromed University of Fes (UEMF), Morocco
- The African Scientific, Research and Innovation Council (ASRIC)
- National Center for Nuclear Energy, Science and Technology (CNESTEN)
Zitieren
APA
Suleiman, G., Eljabouri, A., Chihab, A., Bentaleb, N., Aiboud, A., Brahmi, N. E., & Kazzouli, S. E. (2026). Design, Synthesis, In Vitro, and In Silico Assessment of Fluoroquinolone‐Sulfonamide Hybrids as Promising Antibacterial Agents. Chemistry & Biodiversity, 23(5). https://doi.org/10.1002/cbdv.71318
Vancouver
Suleiman G, Eljabouri A, Chihab A, Bentaleb N, Aiboud A, Brahmi NE, et al. Design, Synthesis, In Vitro, and In Silico Assessment of Fluoroquinolone‐Sulfonamide Hybrids as Promising Antibacterial Agents. Chemistry & Biodiversity. 2026;23(5). doi:10.1002/cbdv.71318
BibTeX
@article{Suleiman2026,
author = {Suleiman, Garba and Eljabouri, Abdelkarim and Chihab, Abdelali and Bentaleb, Naoual and Aiboud, Abdelmjid and Brahmi, Nabil El and Kazzouli, Saïd El},
title = {Design, Synthesis, In Vitro, and In Silico Assessment of Fluoroquinolone‐Sulfonamide Hybrids as Promising Antibacterial Agents},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {5},
doi = {10.1002/cbdv.71318}
}
EUVIMED